Markus Jaquemar
Corporate Officer/Principal bei GENTIAN DIAGNOSTICS
Vermögen: - $ am 30.04.2024
Profil
Markus Jaquemar is currently the Chief Commercial Officer at Gentian Diagnostics ASA. Previously, he held positions as the Chief Executive Officer-Germany at Beckman Coulter, Inc., Head-Sales & Marketing at CytoCore, Inc., Principal at Agilent Technologies, Inc., and Head-Business Development, Sales & Marketing at Anagnostics Bioanalysis GmbH.
He is a graduate of Vienna University of Economics & Business.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
GENTIAN DIAGNOSTICS ASA
-.--% | 31.12.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Markus Jaquemar
Unternehmen | Position | Beginn |
---|---|---|
GENTIAN DIAGNOSTICS | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Markus Jaquemar
Unternehmen | Position | Ende |
---|---|---|
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Vertrieb & Marketing | - |
Beckman Coulter, Inc.
Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Corporate Officer/Principal | - |
AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Anagnostics Bioanalysis GmbH
Anagnostics Bioanalysis GmbH Miscellaneous Commercial ServicesCommercial Services Anagnostics Bioanalysis GmbH develops systems and tests for medical research diagnostics. It specializes in developing systems and tests for multiplex clinical and medical research diagnostics. The firm also provides solutions in the fields of drugs abuse screening, severe infections and oncology diagnostics. The company was founded by Christoph Reschreiter and Bernhard Ronacher in 2006 and is headquartered in St. Valentin, Austria. | Vertrieb & Marketing | - |
Ausbildung von Markus Jaquemar
Vienna University of Economics & Business | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
AGILENT TECHNOLOGIES, INC. | Health Technology |
GENTIAN DIAGNOSTICS | Health Technology |
Private Unternehmen | 3 |
---|---|
Beckman Coulter, Inc.
Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Health Technology |
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Health Technology |
Anagnostics Bioanalysis GmbH
Anagnostics Bioanalysis GmbH Miscellaneous Commercial ServicesCommercial Services Anagnostics Bioanalysis GmbH develops systems and tests for medical research diagnostics. It specializes in developing systems and tests for multiplex clinical and medical research diagnostics. The firm also provides solutions in the fields of drugs abuse screening, severe infections and oncology diagnostics. The company was founded by Christoph Reschreiter and Bernhard Ronacher in 2006 and is headquartered in St. Valentin, Austria. | Commercial Services |